Stay updated on Pembrolizumab Maintenance in sNSCLC Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab Maintenance in sNSCLC Clinical Trial page.

Latest updates to the Pembrolizumab Maintenance in sNSCLC Clinical Trial page
- Check3 days agoChange DetectedAdded a general site notice about potential delays due to government funding and updated the revision tag to v3.4.1, removing the previous v3.4.0 tag. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.5%

- Check10 days agoChange DetectedThe page now shows a glossary toggle and new QC metadata (Last Update Submitted that Met QC Criteria) and a new revision (Revision: v3.4.0), while older QC metadata (Last Update Submitted that met QC Criteria), No FEAR Act data, and the previous revision (v3.3.4) were removed.SummaryDifference0.2%

- Check17 days agoNo Change Detected
- Check25 days agoChange DetectedThe page revision was updated from v3.3.3 to v3.3.4 without changes to study content or navigation. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check46 days agoChange DetectedFooter updates display Revision: v3.3.3 and removal of the HHS Vulnerability Disclosure link along with Revision: v3.3.2, a non-significant change; To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check75 days agoChange DetectedRevision updated from v3.2.0 to v3.3.2 on the page.SummaryDifference0.1%

- Check82 days agoChange DetectedA notice regarding potential delays and outdated information due to a lapse in government funding has been removed.SummaryDifference0.4%

Stay in the know with updates to Pembrolizumab Maintenance in sNSCLC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab Maintenance in sNSCLC Clinical Trial page.